These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16303304)

  • 1. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
    Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.
    Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
    Raval S; Raval P; Bandyopadhyay D; Soni K; Yevale D; Jogiya D; Modi H; Joharapurkar A; Gandhi N; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3919-24. PubMed ID: 18585912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta.
    Garcia Collazo AM; Koehler KF; Garg N; Färnegårdh M; Husman B; Ye L; Ljunggren J; Mellström K; Sandberg J; Grynfarb M; Ahola H; Malm J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1240-4. PubMed ID: 16338239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of halogen bonds in thyroid hormone receptor selectivity: pharmacophore-based 3D-QSSR studies.
    Valadares NF; Salum LB; Polikarpov I; Andricopulo AD; Garratt RC
    J Chem Inf Model; 2009 Nov; 49(11):2606-16. PubMed ID: 19863110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of high affinity thyromimetics containing a phenyl-naphthylene core.
    Hangeland JJ; Friends TJ; Doweyko AM; Mellström K; Sandberg J; Grynfarb M; Ryono DE
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4579-84. PubMed ID: 16099653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L; Polikarpov I; Skaf MS
    J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
    Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
    J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
    Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
    J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a thyroid hormone receptor targeting conjugate.
    Zheng J; Hashimoto A; Putnam M; Miller K; Koh JT
    Bioconjug Chem; 2008 Jun; 19(6):1227-34. PubMed ID: 18507428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.
    Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thyroid hormones and their precursors I. Biochemical properties].
    Tóth G; Noszál B
    Acta Pharm Hung; 2013; 83(2):35-45. PubMed ID: 23926648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain.
    Nunes FM; Aparicio R; Santos MA; Portugal RV; Dias SM; Neves FA; Simeoni LA; Baxter JD; Webb P; Polikarpov I
    Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1867-70. PubMed ID: 15388935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
    Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
    J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.
    Garg N; Li YL; Garcia Collazo AM; Litten C; Ryono DE; Zhang M; Caringal Y; Brigance RP; Meng W; Washburn WN; Agback P; Mellström K; Rehnmark S; Rahimi-Ghadim M; Norin T; Grynfarb M; Sandberg J; Grover G; Malm J
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4131-4. PubMed ID: 17543524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonists.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Matsuzawa A; Nagano R; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2013 Feb; 21(3):592-607. PubMed ID: 23276448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic applications of thyroid hormone analogs.
    Brenta G; Danzi S; Klein I
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):632-40. PubMed ID: 17710084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D QSAR studies on thyroid hormone receptor ligands.
    Valadares NF; Castilho MS; Polikarpov I; Garratt RC
    Bioorg Med Chem; 2007 Jul; 15(13):4609-17. PubMed ID: 17467994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.